Sanz del Olmo, N.; Holota, M.; Michlewska, S.; Gómez, R.; Ortega, P.; Ionov, M.; de la Mata, F.J.; Bryszewska, M.
Copper (II) Metallodendrimers Combined with Pro-Apoptotic siRNAs as a Promising Strategy Against Breast Cancer Cells. Pharmaceutics 2020, 12, 727.
https://doi.org/10.3390/pharmaceutics12080727
AMA Style
Sanz del Olmo N, Holota M, Michlewska S, Gómez R, Ortega P, Ionov M, de la Mata FJ, Bryszewska M.
Copper (II) Metallodendrimers Combined with Pro-Apoptotic siRNAs as a Promising Strategy Against Breast Cancer Cells. Pharmaceutics. 2020; 12(8):727.
https://doi.org/10.3390/pharmaceutics12080727
Chicago/Turabian Style
Sanz del Olmo, Natalia, Marcin Holota, Sylwia Michlewska, Rafael Gómez, Paula Ortega, Maksim Ionov, Francisco Javier de la Mata, and Maria Bryszewska.
2020. "Copper (II) Metallodendrimers Combined with Pro-Apoptotic siRNAs as a Promising Strategy Against Breast Cancer Cells" Pharmaceutics 12, no. 8: 727.
https://doi.org/10.3390/pharmaceutics12080727
APA Style
Sanz del Olmo, N., Holota, M., Michlewska, S., Gómez, R., Ortega, P., Ionov, M., de la Mata, F. J., & Bryszewska, M.
(2020). Copper (II) Metallodendrimers Combined with Pro-Apoptotic siRNAs as a Promising Strategy Against Breast Cancer Cells. Pharmaceutics, 12(8), 727.
https://doi.org/10.3390/pharmaceutics12080727
